definiens: ) from and against any L iabilities ( as defined in the Santaris Agreement ) t hat the [COMPANY] Indemnified Party incurs or suffers res ulting from or arising out of any Third Party claim s arising out of the Development, Manufacture or Comm ercialization of ( i ) any Reversion Product by, on behalf of or under the authority of, Santaris, its Affiliates or sublicensees, including any patent infringement or the personal injury or death of any person as a result of use of any Reversion Product or ( ii ) any product containing an LNA Compound Targeti ng a Miragen Target in a terminated Target Family, on behalf of or under the authority of, Santaris, i ts Affiliates or sublicensees, including any patent infringement or the personal injury or death of any person as a result of use of any such product, exc ept in each case to the extent caused by the gross neglige nce or willful misconduct of [COMPANY] or any [COMPANY] Indemnified Party . ” [ * ] = Certain confidential information contained in this document, marked by brackets, is filed with t he Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended